Abstract
The inclination of dog owners to vaccinate was investigated by sending a questionnaire to randomly selected Swedish dog-owning households. According to the owners (n = 538), 86.7% of the dogs had been vaccinated against CPV and 95.8% had been vaccinated against CD/ICH. The inclination to vaccinate mixed breeds was significantly lower than the inclination to vaccinate pure-bred dogs. In a second study titres of CPV, CD and CAV-1 virus antibodies were measured in 176 randomly selected dogs with known vaccination histories. CPV antibody titres ≥1:80 were detected in 70.9% of the CPV vaccinated dogs. There was a significant difference in the fraction of dogs with CPV titre ≥1:80 between the group last vaccinated with live attenuated vaccine and the group last vaccinated with inactivated vaccine. Titres of CD and CAV-1 virus antibodies ≥1:16 were found in 86.1% and 91.6% of the vaccinated dogs respectively. The fraction of dogs with CAV-1 antibody titres ≥1:16 was significantly greater in the group that received inactivated CAV-1 vaccine than in the group vaccinated with attenuated live CAV-2 vaccine. Approximately 50% of the dogs were booster vaccinated against all 3 diseases at one year of age.
Keywords: adeno virus, vaccination
Sammanfattning
Djurägares benägenhet att vaccinera sιna hundar undersöktes hos slumpvιs utvalda hundägande svenska hushåll. Enligt ägarna (n = 538) hade 87,7% av hundarna blivιt vaccinerade någon gång mot CPV (canine parvo vιrus) och 95,8% hade blιvιt vaccinerade mot CD/ICH (canιne dιstemper/infectιous canιne hepatιtis). Benägenheten att vaccιnera blandrashundar var sιgnifikant lägre jämfört med rasrena hundar. I en andra del av studιen analyserades antikroppshalten mot CPV CD och CAV-1 hos 176 slumpvιs utvalda hundar med känd vaccιnationsbakgrund. CPV antιkroppshalter ≥1:80 uppmättes hos 70,9% av de vaccinerade hundarna. Andelen hundar som nådde ≥1:80 ι tιter mot CPV var sιgnιfikant högre i den grupp som var vaccinerade med levande modιfierat parvovιrusvaccιn jämfört med hundar vaccιnerade med avdödat vaccιn. Antιkroppstιtrar mot CD och CAV-1 ≥1:16 uppmättes hos 86,1% och 91,6% respektιve. Andelen hundar med CAV-1 antιkroppar ≥1:16 var signifikant högre ι den grupp hundar som vaccιnerats med ιnaktιverat CAV-1 vaccιn jämfört med den grupp som vaccinerats med modifierat levande CAV-2 vaccιn. Ungefär 50% av hundarna booster vaccιnerades mot alla tre sjukdomarna vιd cirka ett års ålder.
Full Text
The Full Text of this article is available as a PDF (1.6 MB).
Acknowledgments
This study was supported by grants from the Swedish Kennel club and Agria Insurance. The support from Masterfood ab is greatly appreciated.
References
- Adelus-Neveu F, Saint-Gerand AL, Fayet G, Wiedemann C. Hundestaupe: Lehren aus einer Epizootie in Frankreich. (Canine Distemper: Experience from an epizootic in France). Praktische Tierartzt. 1991;72:869–871. [Google Scholar]
- Appel M, Robson D. A microneutralization test for canine distemper. Amer. J vet. Res. 1973;34:1459–1463. [PubMed] [Google Scholar]
- Blixenkrone-Möller M, Svansson V, Have P, Orvell C, Appel M, Pedersen IR, Dietz HH, Henriksen P. Studies on manifestations of canine distemper virus infection in an urban dog population. Vet. microbiol. 1993;37:163–173. doi: 10.1016/0378-1135(93)90190-I. [DOI] [PubMed] [Google Scholar]
- Buonavoglia C, Tollis M, Buonavoglia D, PuccineA Response of pups with maternal derived antibody to modified-live canine parovovirus vaccine. Comp. Immun. Microbiol, infect. Dis. 1992;15:281–283. doi: 10.1016/0147-9571(92)90007-E. [DOI] [PubMed] [Google Scholar]
- Burtonboy S, Charlier P, Hertoghs J, Lobmann M, Wiseman A, Woods S. Performance of a high titre attenuated canine parvovirus vaccine in pups with maternally derived antibody. Vet. Rec. 1991;129:377–381. doi: 10.1136/vr.128.16.377. [DOI] [PubMed] [Google Scholar]
- Fischerman B, Scarnell J. Persistence of protection after vaccination against infectious canine hepatitis virus (CAV/1) Vet. Rec. 1976;99:599. doi: 10.1136/vr.99.25-26.509. [DOI] [PubMed] [Google Scholar]
- Grondalen J, Sjerve E. Infectious disesases among dogs and cats in Europe. The European J of Comp. Animal Pract. 1994;4:16–19. [Google Scholar]
- Miyamoto T, Taura Y, Une S, Yoshitake M, Nakama S, Watanbe S. Changes in blastogenetic response of lymphocytes and delayed type hypersensitivity responses after vaccination in dogs. J vet. Med. Sci. 1992;54:945–950. doi: 10.1292/jvms.54.945. [DOI] [PubMed] [Google Scholar]
- Miyamoto T, Taura Y, Une S, Yoshitake M, Nakama S, Watanbe S. Immunlogical response to polyvalent canine vaccines in dogs: J vet. Med. Sci. 1995;57:347–349. doi: 10.1292/jvms.57.347. [DOI] [PubMed] [Google Scholar]
- O’Brien SE. Serologic response of pups to the low-passage, modified live canine parvovirus-2 component in a combination vaccine. J Amer. vet. med. Ass. 1994;204:1207–1209. [PubMed] [Google Scholar]
- Olson P, Hedhammar, Klingebom B. Nya rekom-mendationer for vaccination av hund. (New recommendations for vaccination of dogs). Svensk Veterinärtidning. 1987;39:829–831. [Google Scholar]
- Olson P, Klingebom B, Hedhammar Serum antibody response to canine parvovirus, canine aden-ovirtus-1, and canine distemper virus in dogs with known status of immunization: Study of dogs in Sweden. Amer. J vet. Res. 1988;49:1460–1644. [PubMed] [Google Scholar]
- Phillips TR, Jensen JL, Rubino MJ, Yang WC, Shultz RD. Effects of vaccines on the canine immune system. Can. J Vet. Res. 1989;53:154–160. [PMC free article] [PubMed] [Google Scholar]
- Pollock RVH, Carmichael LE. Dog response to inactivated canine parvovirus and feline panleukopenaia virus vaccines. Cornell Vet. 1982;72:16–35. [PubMed] [Google Scholar]
- Pollock RVH, Coyne MJ. Canine Parvovirus. Vet. Clininics N Am. Small Animal. 1993;23:555–568. doi: 10.1016/S0195-5616(93)50305-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rimmelzwaan GF, Juntti N, Klingeborn B, Groen J, UytdeHaag FGCM, Osterhaus ADME. Evaluation of enzymelinked immunoabsorbent assays based on monoclonal antibodies for the serology and antigen detection in canine parvovirus infections. Vet. Quartly. 1990;12:14–20. doi: 10.1080/01652176.1990.9694236. [DOI] [PubMed] [Google Scholar]
- Robertson ID, Shaw SE, Clark WT. The use of health management practices by a randomly selected group of dog owners in Perth. Austr. vet. Practi. 1991;27:126–130. [Google Scholar]
- Tennant BJ, Gaskell RM, Jones RC, Gaskell CJ. Prevalence of antibodies to 4 major canine viral diseases in dogs in a Liverpool hospital population. J Small Animal Pract. 1991;32:175–179. doi: 10.1111/j.1748-5827.1991.tb00539.x. [DOI] [Google Scholar]
- Wierup M, Olson P, Hedhammar, Klingeborn B, Karlsson K-A. Evaluation of a killed feline panleukopenia virus vaccine against canine parvoviral enteritis in dogs. Amer. J vet. Res. 1982;43:2183–2187. [PubMed] [Google Scholar]
